The epididymis is responsible for posttesticular sperm maturation. Sperm maturation is dependent on the luminal microenvironments along the epididymis. Though the role of the epididymis is well established, the molecular and cellular mechanisms responsible for sperm maturation remain to be elucidated, particularly in the human, as limited biological tools exist. We have established the first stable epithelial cell lines transformed with SV40 large T antigen (LTAg) from two regions of the human adult epididymis. The cell lines are composed of homogenous populations of diploid principal cells that possess ultrastructural characteristics similar to those of human principal cells in vivo. These cells express transcripts for adherens (cadherins CDH1 and CDH2) and tight (claudins CLDN1, CLDN2, CLDN3, CLDN4, CLDN7, and CLDN8) junctions as well as desmosomes (desmoplakin, DSP). Transepithelial resistance (TER) measurements in fertile human caput epididymal cell line 1 (FHCE1) as well as the immunolocalization of tight junctional protein 1 (TJP1), occludin, and CLDN1 indicate that these cells form functional tight junctions. Furthermore, knockdown of CLDN1, CLDN3, CLDN4, or CLDN7 using specific siRNAs resulted in significant decreases in TER, suggesting that these CLDNs are essential for the barrier function of the blood-epididymis barrier. Disruption of CLDN1, CLDN3, CLDN4, and CLDN7 could, therefore, lead to epididymal dysfunction, resulting in male infertility.
INTRODUCTION
In mammals, the epididymis plays a major role in sperm maturation, transport, protection, and storage. Testicular spermatozoa are immature and need to transit through the epididymis to acquire motility and the ability to fertilize [1, 2] . Specific microenvironments in the lumen of the epididymis are essential for sperm maturation. The creation and maintenance of this luminal environment is due in part to the bloodepididymis barrier [3] , which consists of apical tight junctions localized between adjacent principal cells that regulate paracellular transport between the lumen and the blood [4] . Epididymal tight junctions were first described by Friend and Gilula [5] in the rat as a highly developed junctional complex. Suzuki and Nagano [6, 7] showed that the strands of the tight junctions increased in complexity during development until Postnatal Day 37. Hinton and Howards [8] first showed that the caput epididymidis was relatively impermeable to inulin, thereby demonstrating the presence of a tissue barrier. However, it is only recently that molecular components of the human blood-epididymis barrier have been described. Dubé et al. [9] demonstrated that in human the composition of this barrier is complex and varies along the duct.
As in the rat and mouse, human epididymal tight junctions are comprised of several peripheral (tight junction protein [TJP] , also known as zonula occludens) and transmembrane (occludin, claudins) proteins [9] [10] [11] [12] [13] [14] . Claudins (CLDN) are thought to be the molecular basis of tight junctions [15] . Several CLDNs can be expressed in a specific tissue, defining its permeability characteristics [16] , but it is unusual to find as many as 19 CLDNs expressed in one particular tissue [17] , as is the case for the human epididymis [9] . In addition, the differential expression of several CLDNs along the human epididymal duct may represent a key element in regulating the changing intraluminal environment necessary for epididymal functions.
Male factor infertility affects almost half of infertile couples [18, 19] , and in 25% of cases the causes are unknown [20] . Several lines of evidence have suggested that the epididymis is implicated in male infertility. A recent study demonstrated that a larger number of genes exhibit differential expression in the caput epididymidis of nonobstructive, azoospermic patients as compared to that of patients with proven fertility [21] . Among these genes, several encoded water and ion channels that can directly influence the luminal environment of the epididymis, while others are known to regulate components of the tight junction [22] . In addition, cytoplasmic immunolocalization of the tight junctional proteins TJP1 and CLDN10, normally localized exclusively to the tight junctions, suggested that the blood-epididymis barrier was altered in the epididymis of infertile patients [21] . However, in a tissue where such a large number of CLDNs are expressed, the significance of a loss, or mistargeting, of a single CLDN is difficult to evaluate. Therefore, it is important to identify the role of specific CLDNs in order to understand the impact that altered CLDN expression may have on male fertility.
CLDNs form ion-selective channels whose permeability properties depend on the combination and copolymerization of CLDNs [23] . In order to assess the role of specific CLDNs in the human epididymis, we need to develop biological tools that will allow the study of cell-cell interactions. The difficulty in obtaining quality human epididymal tissues and the limited life span of primary cell cultures remain a significant obstacle for understanding human epididymal functions [24] [25] [26] [27] . Several cell lines have been developed in mouse, rat, and dog, but their applicability to humans has not been established and may be limited, given the morphological differences between the human epididymis and that of certain laboratory species [28] [29] [30] [31] [32] . Thus, even if the composition of the blood-epididymis barrier is similar between rodents and humans, novel human in vitro models would be necessary to study the role of specific junctional proteins, such as CLDNs, in human epididymal pathologies.
The objective of the present study was to develop and characterize human epididymal cell lines in order to assess the role of CLDN1, CLDN3, CLDN4, and CLDN7, which have been shown to be important for barrier function [23, 33] , in epididymal tight junctions.
MATERIALS AND METHODS

Tissue Preparation
Epididymides were obtained from a 23-yr-old patient with active spermatogenesis undergoing radical orchidectomy for localized testicular cancer (confined within testicular tunica albuginea with no sign of epididymal lesion or obstruction). Tissues were surgically removed and placed in cold culture medium (Dulbecco modified Eagle medium [DMEM]/Ham F12 culture medium containing glutamine [2 mM], penicillin [50 U/ml], and streptomycin [50 lg/ml]; Sigma-Aldrich, Mississauga, ON, Canada) and were processed under aseptic conditions within 1 h of surgery. Epididymides were divided into three regions: the caput, corpus, and cauda epididymidis (see Dubé et al. [21] for a schematic representation of human epididymal regions). The study was conducted with the approval of the McGill University ethics committee for research on human subjects after informed consent was obtained from the patient.
Primary Cell Culture
Cells from the different epididymal regions were isolated according to the methods of Dufresne et al. [32] . Briefly, tissue fragments (2-3 mm 3 ) were placed in DMEM/Ham F12 culture medium containing glutamine (2 mM), penicillin (50 U/ml), streptomycin (50 lg/ml), collagenase (2 mg/ml; Life Technologies, Inc., Burlington, ON, Canada), and DNase (20 U/ml; Promega, Ottawa, ON, Canada). The fragments were digested twice for 50 min each time in a shaking water bath at 378C. Tissues were dissociated between digestions by gently pipetting the small tissue fragments, and these were left to sediment to the bottom of the flasks. The supernatant was then replaced with fresh medium. At the end of the final digestion, the cells were centrifuged (34 3 g) for 3 min, and the pellet was resuspended in DMEM/Ham F12 culture medium containing antibiotics and nutrients (50 U/ml penicillin, 50 lg/ml streptomycin, 2 mM L-glutamine, 5 nM testosterone, 10 lg/ml insulin, 10 lg/ml transferrin, 80 ng/ml hydrocortisone, 10 ng/ml epidermal growth factor, 10 ng/ml cAMP, 2 ng/ml sodium selenium, 200 ng/ml tocopherol, 200 ng/ml retinol, and 1% fetal bovine serum [FBS] ; Sigma-Aldrich). Small tissue fragments were then placed in 6-or 24-well plates coated with collagen IV (BD Biosciences, Mississauga, ON, Canada) and incubated in a humidified chamber at 328C with 5% CO 2 . Once the cells adhered to the bottom of the wells, the culture medium was changed every 48 h for 12-18 days, until 40%-80% confluence was reached. The cells were subsequently used for immortalization.
Immortalization of Epididymal Cells
Epididymal cells were transfected with a pBK-CMV plasmid containing the SV40 LTAg and neomycin resistance genes (a kind gift of Dr. D. W. Silversides, Animal Reproduction Research Center, University of Montreal) using Fugene 6 (70%-80% confluent) according to the manufacturer's instructions (3:2 ratio of Fugene 6:DNA; Roche Diagnostics, Laval, QC, Canada). Stable transfectants were selected by incubating the cells in media containing neomycin (200 lg/ml G418; GIBCO BRL, Burlington, ON, Canada) for 14 days. Cell lines were generated from subpopulations of resistant cells ( Table 1) . The cells were then selected by isolating clusters from the culture wells with cloning cylinders, followed by serial dilution and passaging. The homogeneity of the cell lines obtained after selection was verified by electron microscopy and by FACS based on the complexity and size of the cells (data not shown). It should be noted that the selection of a single cell with the cloning cylinder resulted in nonproliferating cells, suggesting a need for cellcell interaction in the proliferation of human epididymal principal cells.
Cells were cultured in DMEM/Ham F12 medium containing antibiotics and nutrients, as previously described, as well as 10% FBS. The culture medium was changed every 48 h.
Electron Microscopy
Cells were trypsinized (0.05% trypsin and 0.53 mM ethylenediaminetetraacetic acid), gently aspirated, and centrifuged (300 3 g) into a 1.5-ml centrifuge tube or grown on plastic chamber slides (Nalge Nunc International, Naperville, IL) before fixation with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer for 24 h. The cells were then washed in 0.1 M sodium cacodylate buffer and postfixed in 1% ferrocyanide-reduced osmium tetroxide, dehydrated in ethanol and propylene oxide, and embedded in EPON. Thin sections were cut, mounted on copper grids, counterstained with uranyl acetate and lead citrate, and examined with an electron microscope (Tecnai 12; FEI, Hillsboro, OR).
Cell Cycle Analysis
Cells were trypsinized, recovered by centrifugation (1000 3 g for 7 min), and washed twice in PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na 2 HPO 4 , and 1.5 mM KH 2 PO 4 ; pH 7.4). Cells were fixed by resuspending the pellet in icecold ethanol and kept on ice for 30 min. The cells were then washed three times in PBS containing 2% FBS. The pellet was finally resuspended in a solution containing 0.1% sodium citrate, 0.3% NP-40, 100 lg/ml RNase A, and 50 lg/ ml propidium iodide. DNA content of 2 3 10 6 cells per sample was analyzed using a FACScan apparatus (Becton Dickinson, Oakville, ON, Canada). THP1 cells (a kind gift of Dr. D. Girard, INRS-Institut Armand-Frappier, Laval, QC, Canada) were used as control diploid cells.
Cell Growth
Aliquots of 2500 cells per well were plated in 96-well culture plates coated with collagen IV. The number of cells was determined using Trypan blue staining and a hemocytometer (Invitrogen, Inc., Burlington, ON, Canada). The next day, once the cells had adhered, medium was changed, and this first time point was assigned as time zero. Each time point was done in triplicate. Medium was changed every 24 h. At different time points, the culture medium was removed from three of the wells and replaced with 20 ll methylthiazolyldiphenyl-tetrazolium bromide (MTT) solution (0.5 mg/ml in culture medium; Sigma-Aldrich) to measure cellular proliferation [32] . After 2 h, the MTT solution was removed, and the formazan crystals were solubilized in 200 ll dimethylsulfoxide. Absorbance (570 nm) was measured using a microtiter plate reader (Power Wave X; Bio-Tek Instruments, Inc., Winooski, VT). The doubling time was calculated as the inverse of the slope of a semilog plot of the absorbance in function of time, in the linear portion of the graph (the logarithmic growth phase). Data was presented as mean 6 SEM.
Immunofluorescence
Indirect immunofluorescence experiments were done using several antibodies, including a rabbit polyclonal anti-cytokeratin (cat #18-0059; Zymed Lab., Inc., San Francisco, CA), a mouse monoclonal anti-vimentin (VIM; cat #ab20346; Abcam, Inc., Cambridge, MA), a rabbit polyclonal anti-TJP1 (cat #61-7300; Zymed Lab., Inc.), a rabbit polyclonal anti-occludin (OCLN; cat #71-1500; Zymed Lab., Inc.), and a rabbit polyclonal anti-CLDN1 (cat #51-7900; Zymed Lab., Inc.). Cells were grown on plastic chamber slides (Nalge Nunc International). Cells were fixed in methanol at À208C for 10 min. 
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For cytokeratin and VIM localization, cells were permeabilized in a solution of 0.3% Triton X-100 in PBS for 15 min at room temperature. Cells were then washed in PBS and blocked in the same buffer containing 5% bovine serum albumin (BSA) for 30 min at 378C (cytokeratin, VIM) or overnight at 48C (TJP1, OCLN), followed by three 5-min washes in PBS. Samples were then incubated with primary antibodies (cytokeratin, 13.6 lg/ml; VIM, 1 lg/ml; TJP1, 2.5 lg/ml; OCLN, 25 lg/ml) for 90 min at room temperature and washed three times for 5 min with PBS. For CLDN1 localization, cells were blocked in PBS containing 5% BSA for 60 min at 378C, incubated overnight at 48C with the primary antibody (12.5 lg/ml), and washed three times for 5 min with PBS. Cells were subsequently incubated with Alexa Fluor 488-conjugated anti-rabbit or anti-mouse (2 lg/ml; Molecular Probes, Leiden, The Netherlands) secondary antibody for 45 min at 378C. Cells were then washed three times in PBS and mounted with Vectashield mounting medium containing propidium iodide (Vector Laboratories, Burlington, ON, Canada). Sections were examined with a Leica DMRE microscope (Leica Microsystems, Inc., Bannockburn, IL) or with a Nikon Eclipse E800 microscope equipped with a BioRad Radiance 2000 confocal imaging system (Bio-Rad Laboratories, Hercules, CA).
RT-PCR
Total cellular RNA was isolated using the Illustra RNAspin Mini Isolation kit (GE Healthcare, Baie D'Urfe, QC, Canada) according to the manufacturer's instructions. Total RNA (500 ng) was reverse transcribed using an oligo (dT) 16 primer (R&D Systems, Inc., Minneapolis, MN). Gene-specific PCR was subsequently done to identify the presence of different transcripts (see Table 2 ) using the following program: 948C for 5 min, 30-40 cycles of 948C for 30 sec; melting temperature for 30 sec, 728C for 1 min; and cooled to 48C. Primer sequences for CLDNs are identical to those described in Dubé et al. [9] . PCR products were separated on an agarose gel (1%-2%) and visualized with ethidium bromide using a Fluor-S Multi-Imager densitometer (Bio-Rad Laboratories, Mississauga, ON, Canada). PCR amplification was also done on RNA to confirm that the sample was free of contaminating genomic DNA. RNA extracted from human epididymis and kidney (Biochain, Hayward, CA) were used as positive controls.
Transepithelial Resistance
Cells were seeded at a density of 1 3 10 5 cells per milliliter on Costar Transwell 6.5-mm cell culture inserts (pore size 0.4 lm; Corning, Lowell, MA). Cells were grown in DMEM/Ham F12 culture medium containing antibiotics (50 U/ml penicillin and 50 lg/ml streptomycin), 2 mM L-glutamine, and 5% FBS. Once total confluence was reached, cells were cultured in medium containing 1.8 mM CaCl 2 for 48 h, and transepithelial resistance (TER) was measured at regular intervals using an EVOM epithelial voltohmmeter with a STX2 electrode (WPI, Inc., Sarasota, FL). TER was normalized to the area of the filter after removal of background resistance of a blank filter that contained only medium. TER was measured as ohms times square centimeters. All TER measurements were done in triplicate wells at all of the time points.
RNA Interference
Small interfering RNA (siRNA; final concentration 5 nM) against CLDN1, CLDN3, CLDN4, CLDN7, and a nonsense siRNA (5 nM; Qiagen, Mississauga, ON, Canada) were transfected into FHCE1 using HiPerfect Transfection Reagent according to the manufacturer's instructions (Qiagen). Cells were seeded on inserts at the time of transfection and, 24 h after transfection, were exposed to CaCl 2 as previously described. TER was measured in triplicate wells at regular intervals for 48 h. At various time intervals posttransfection, cells were lysed and levels of CLDNs were monitored by RT-PCR, as previously described, and by Western blot. Untreated cells, cells treated with transfection reagent, and cells transfected with the nonsense siRNA were used as controls. This experiment was repeated at least three times.
Western Blot
Cells were lysed in cold RIPA buffer (PBS, 1% IGEPAL, 0.5% sodium deoxycholate, and 0.1% SDS) supplemented with 10 lg/ml phenylmethylsulfonyl fluoride and a protease inhibitor cocktail (Sigma, St. Louis, MO) and then centrifuged at 10 000 3 g for 10 min at 48C to remove cellular debris. Protein concentrations in the cell extracts were determined using the Bradford method (Bradford reagent; Sigma). Samples were stored at À808C until electrophoresis. Proteins (25 lg) were diluted in Laemmli loading buffer, heated at 948C for 7 min, separated by electrophoresis on a 12% SDS-polyacrylamide gel, and transferred onto a nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA). The resulting blots were stained with 0.6% Ponceau red S to evaluate transfer efficiency. Membranes were blocked 2 h at room temperature with 5% nonfat dry milk diluted in Tris-buffered saline (TBS; 20 mM Tris-HCl and 500 mM NaCl; pH 7.5) and subsequently incubated overnight at 48C or 2 h at room temperature with either a polyclonal anti-CLDN1 antibody (0.5 lg/ml; Zymed), a polyclonal anti-CLDN3 antibody (0.8 lg/ml; Zymed), a polyclonal anti-CLDN4 antibody (2 lg/ml; Santa Cruz), or a polyclonal anti-CLDN7 antibody (1 lg/ml; Zymed) diluted in the blocking buffer. Membranes were then washed three times in TBS with 0.1 % Tween-20 (Fisher Scientific, Ottawa, ON, Canada) for 10 min and then probed with a horseradish peroxidase-conjugated anti-rabbit, anti-mouse, or anti-goat secondary antibody (0.2 lg/ml; Santa Cruz). Once again, membranes were washed three times for 10 min in TBST. Detection was done using the Lumilight Western Blotting Substrate (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions. A monoclonal anti-actin antibody (6.4 lg/ml; Sigma) was used to normalize the protein amounts on the blots.
RESULTS
Establishment of Human Epididymal Cell Lines
Primary cell cultures were derived from the epididymis of a 23-yr-old man with active spermatogenesis and immortalized with a plasmid containing the coding region of the SV40 LTAg. We obtained five cell lines, four from the caput (FHCE1-4) and one from the corpus epididymidis (FHSE1), as described in Table 1 . Though cells from the cauda epididymidis from several patients were transfected with the pBK-CMV 
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plasmid, we were unable to maintain these cells in culture over a prolonged period of time. Ultrastructural analyses of the different cell lines indicated that they were composed of cells that share similar morphological characteristics with epithelial principal cells in vivo [9] . These characteristics included the presence of microvilli, a large and irregular nucleus, endosomal elements, secreted vesicles resembling epididymosomes, an extensive Golgi network, and junctional complexes (Fig. 1) . Furthermore, the cell lines expressed cytokeratin, an epithelial cell marker, but not vimentin, a mesenchymal cell marker, at both the mRNA and protein levels (Fig. 2) . These results support the notion that the immortalized epididymal cell lines are of epithelial origin. Furthermore, these cells, which have been passaged at least 20 times, are diploid ( Fig. 3) and have a doubling time of approximately 13 to 20 days (Fig. 4) .
Characterization of the Human Epididymal Cell Lines
RT-PCR was used to verify the presence of transcripts for several epididymal principal cell markers. NPC2 (also known as HE1), SPAG11B (also known as HE2), CD52 (also known as HE5), and DCXR (also known as P34H), but not CRISP1 and SPINLW1 (also known as EPPIN2), were expressed in the cell lines (Fig. 5) . The expression of SLC9A3, a Naþ/H exchanger also known as NHE3 that has been shown to be expressed in the epithelium of human efferent ducts but not in the human epididymis [34] , was not expressed in any of the cell lines (Fig. 5) . Human kidney was used as a positive control for SLC9A3 [35] . Transcripts for the androgen (AR) and estrogen receptors (ESR1 and ESR2) as well as for the two isoforms of 4-ene-steroid-5-alpha-reductase (SRD5A1 and SRD5A2) were also assessed (Fig. 6) . The AR was expressed in FHCE1, FHCE2, and FHCE3 cell lines, whereas ESR1, ESR2, SRD5A1, and SRD5A2 were expressed in all of the cell lines. Overall, our cell lines expressed many of the genes characteristic of differentiated principal cells of the adult human epididymis in vivo.
Expression of Genes Encoding Junctional Proteins by the Different Cell Lines
The expression of genes encoding different junctional proteins implicated in adherens (cadherins CDH1 and CDH2) and tight junctions (CLDN1, CLDN2, CLDN3, CLDN4, CLDN7, and CLDN8) as well as desmosomes (desmoplakin, DSP) was verified by RT-PCR (Fig. 7) . CDH1, CDH2, CLDN1, CLDN4, and CLDN8 and DSP were expressed in all cell lines. CLDN3 was expressed in all cell lines derived from the caput epididymidis but not in the cell line derived from the corpus epididymidis. CLDN7 was expressed in all cell lines except in FHCE2 cells.
Formation of Tight Junctions
To assess whether epididymal epithelial cells were able to form functional tight junctions, we monitored TER, a measurement for the paracellular barrier function and integrity of tight junctions. The formation of tight junctions was induced using a calcium-switch model (Fig. 8A) . Several studies have shown that calcium can induce the assembly of tight junctions in vitro [36] . Results were obtained using FHCE1 cells, which resembled in vivo principal cells of the caput epididymidis, the D, and F) , 326 500 (G and H), and 360 000 (I).
1122 main region implicated in sperm maturation, and expressed the highest TER among the different cell lines (data not shown). In FHCE1 cells exposed to calcium (1.8 mM), TER peaked at 24 h after calcium switch (approximately 150 ohms Á cm 2 ) and returned to a lower steady-state level (approximately 20 ohms Á cm 2 ) by 30 h (Fig. 8A ). This peak was not observed when TER was measured in FHCE1 cells that were not exposed to calcium. Immunocytochemical staining was undertaken to assess the presence and localization of TJP1, OCLN, and CLDN1 in FHCE1 cells exposed for 24 h to calcium. TJP1, OCLN, and CLDN1 were localized to the membrane of FHCE1 cells (Fig. 8B) . Some cytoplasmic staining was also noted. These results indicate that FHCE1 cells can be stimulated to form functional tight junctions.
Role of CLDN1, CLDN3, CLDN4, and CLDN7 in Tight Junction Integrity
To assess the physiological role of CLDN1, CLDN3, CLDN4, and CLDN7 in the barrier function of epididymal tight junctions, we knocked down each of these CLDNs in FHCE1 cells by using siRNA. As shown in Figure 9 , A and B, CLDN1, 3, 4, and 7 mRNA and protein levels were reduced 24 and 48 h after the transfection of cells with either CLDN1, CLDN3, CLDN4, or CLDN7 siRNA, respectively. Different controls were used to ensure that the effect was specific to the siRNA. These controls included untreated cells, cells treated with the transfection reagent, and cells transfected with a negative siRNA. CLDN mRNA expression levels remained constant in all of the different control conditions. Furthermore, the effect of the siRNA was specific to each CLDN.
The TER of the FHCE1 cells was assessed in cells where the expression of the different CLDNs was knocked down. The results indicate that the peak in TER normally observed in FHCE1 cells at 24 h was not achieved when CLDN1, CLDN3, CLDN4, or CLDN7 was knocked down. These results suggest that CLDN1, CLDN3, CLDN4, and CLDN7 play an important role in the formation of functional human epididymal tight junctions.
DISCUSSION
We have previously shown using gene expression profiles that epididymal gene expression in nonobstructive, azoospermic, infertile men is altered [21] . However, the lack of biological tools and the difficulty in obtaining human epididymis is a limiting factor in understanding the regulation of human epididymal gene expression and its function. In the present study, we developed a series of human epididymal cell lines derived from adult caput and corpus epididymidis. These are the first human epididymal cell lines derived from adult tissue. Though we were able to develop cell lines from the caput and corpus epididymidis, we were unsuccessful in developing cell lines from the cauda region. This could be due to the microenvironment in which the cells were maintained in vitro. The cauda epididymidis is responsible for sperm storage in a quiescent state. In order to fulfill its function, the luminal microenvironment of the cauda has specific characteristics, such as a low pH and high osmolarity, as compared to the other epididymal regions [2, 37] . It is possible that the principal cells from this region also require these conditions for long-term survival.
The cell lines developed in this study retained some of the characteristics of in vivo principal cells. They exhibited similar ultrastructure, were diploid, and expressed a variety of epididymal markers, at least at the RNA level, which are specifically expressed or highly expressed by human epidid- ymal principal cells (NPC2, SPAG11B, CD52, and DCXR). The lack of expression for VIM and SLC9A3 confirmed that the cells are of epithelial origin and are from the epididymis rather than from the efferent ducts, which are in close proximity to the epididymal tubules in the caput region of the human epididymis [34, 38] . Interestingly, the cells did not express either CRISP1 or SPINLW1. Both of these proteins are implicated in human fertility, and the expression of both genes is altered in nonobstructive azoospermic men [21] . CRISP1 is regulated by androgens and other testicular factors [39, 40] , whereas SPINLW1 is regulated by androgens [41] . It is possible that one of the reasons for the low level or lack of expression in our epididymal cells is related to a requirement for specific testicular factors that regulate their expression. A second possibility is that the immortalization process may alter the expression of these genes. Further studies will be required to address this. The fact that the cells were not completely polarized also suggests that these cells may need an additional nutrient absent from our culture medium or that they need to interact with other cell types such as basal cells.
It is well established that many epididymal functions are regulated by hormones, especially testosterone [42] . Upon its entry in the epididymis, testosterone can be converted into dihydrotestosterone (DHT) by 5a-reductase (SRD5A). Both isoforms of SRD5A that are expressed in our cell lines have also been detected along the human epididymis [43] . Testosterone and DHT bind to the AR, which is expressed along the human epididymis in both principal and basal cells [44] . Most of our human epididymal cell lines expressed the AR. Though the expression of the AR and SRD5A isoforms suggest that the cells have the capacity to respond to androgens, it should be noted that in a rat caput epididymal cell line developed in a fashion similar to the present cell lines, the cells had limited responsiveness to androgens. This was most likely due to the immortalization process with LTAg, which inhibits the interaction between the AR and its cofactor, pRb [32] . Our human cells also expressed Expression of the different transcripts was verified using specific primers. Human epididymis or kidney was used as a positive control. NPC2, SPAG11B, CD52, and DCXR were expressed in the different cell lines, whereas no band was detected for CRISP1, SPINLW1, or SLC9A3. Neg., negative control; Pos., positive control.
both isoforms of the estrogen receptor (ESR1 and ESR2) that are present in the human epididymis [45] . Several lines of evidence suggest an important role for estrogens in the mammalian epididymis during development as well as in the adult [46] . Whether these cells are responsive to androgens and estrogens remains to be established.
Human epididymal tight junctions, which form the bloodepididymis barrier, are composed of a multitude of CLDNs [9] . Studies in rodents have also shown the presence of CLDN1 to 9 in the epididymis [9] [10] [11] 13] . CLDN1, CLDN3, CLDN4, and CLDN7, present in our human cell lines, are localized at tight junctions as well as along the lateral plasma membranes between adjacent principal cells and between principal and basal cells, suggesting additional roles in cell-cell interactions [9] [10] [11] 13] . The widespread distribution of CLDN1, CLDN3, CLDN4, and CLDN7 in rodents and humans, as well as similarities in their localization, suggest an important role for these CLDNs in the epididymis. In addition, the regulation of epididymal tight junctions is complex and multifactorial [4] . For example, in the rat epididymis, segment-specific regulation of CLDN1 involves androgens [10] and the transcription factors SP1 and SP3 [47] . Therefore, it is important to identify key components of the tight junctional complex to study their regulation and involvement in epididymal functions.
A study in MDCK cells reported that a loss in expression of CLDN1, CLDN3, CLDN4, or CLDN7 significantly decreased TER [33] . These CLDNs are considered to be particularly important in maintaining the barrier function, or impermeability, of tight junctions [23] . Our results demonstrated that a knockdown of CLDN1, CLDN3, CLDN4, or CLDN7 can totally inhibit TER and thus the formation or barrier function of human epididymal tight junctions. Therefore, CLDN1, CLDN3, CLDN4, and CLDN7 could play a major role in the proper functioning of the human blood-epididymis barrier. Though these CLDNs are expressed at relatively similar levels throughout the epididymis [9] , alterations in their regulation in different regions could have varying effects on male fertility. Several studies in the rat epididymis suggest that the permeability of the barrier is not similar along the duct [6, 8, 48] . Even if tight junctions in the caput epididymidis of the rat and mouse are numerous and well developed, the degree of permeability of the epithelium is not necessarily correlated with the number of tight junctions. It has been reported that the tight junctions of the caput epididymidis are more permeable than those of the cauda epididymidis [6, 8, 48] . Our FHCE1 cell line can form functional tight junctions, as shown by the expression of different junctional markers (CDH1, CDH2, TJP1, CLDN1, CLDN2, CLDN3, CLDN4, CLDN7, CLDN8, and DSP) and the localization of tight junctional proteins TJP1, OCLN, and CLDN1 to the plasma membrane. The transformed epididymal cells had a TER of approximately 150 ohms Á cm 2 , which is similar to previous reports in both tissue and primary cell cultures derived from the human caput and corpus epididymidis [49, 50] and in primary cell cultures derived from the rat caput epididymidis [51] .
The complex and multifactorial regulation of tight junctional components could, however, explain the rapid reduction in resistance in our cell line 24 h after the calcium switch. It is possible that the cells need additional factors to maintain tight junctions once they are formed. Nonetheless, the level of resistance suggests that epididymal tight junctions in the human caput and corpus epididymidis may form a leaky barrier as compared to the cauda epididymidis, such as has been reported for the rat epididymis [50, 51] or as compared to the vas deferens [52] . The leakiness of the blood-epididymis barrier in the caput and corpus epididymidis is reflected by the expressed CLDNs and is likely to be important for specific ion flow in the epididymis, as has been reported in other leaky epithelia [53] . Dysregulation of CLDNs could result in altered barrier function of the tight junctions, resulting in abnormal sperm maturation or in exposure of sperm to the immune system. Hermo et al. [54] showed that, in cathepsin A-deficient mice, reduced expression and mislocalization of CLDN1, CLDN3, CLDN8, and CLDN10 were associated with altered sperm motility. Dysregulation of CLDN1, CLDN3, CLDN4, and CLDN7 may also affect the homeostasis of the luminal microenvironment by changing paracellular permeability. Electrolytes and fluid secretion are important for proper sperm maturation. In LLC-PK1 and MDCK cells, CLDN4 and CLDN7 have been shown to be involved in the formation of paracellular channels for Cl À and Na þ [33, 55] . Yeung and Cooper [56] reported that changes in luminal Na þ concentrations have dramatic effects on the ultrastructure of the rat epididymal epithelium. In addition, defective Cl À secretion in cystic fibrosis patients results in male infertility due to epididymal obstruction [57] . Male infertility could thus involve multiple epididymal dysfunctions associated with different CLDNs leading to the disruption of the blood-epididymis barrier and/or the paracellular and transcellular transport pathways.
In conclusion, our studies have created a novel approach for examining the role of specific CLDNs in human epididymal tight junctions, as well as other genes involved in epididymal function and sperm maturation. Because CLDNs function as effectors of barrier integrity and paracellular transport, they likely play a critical role in the maintenance of male fertility. The critical functions of CLDN1, CLDN3, CLDN4, and CLDN7 in maintaining the integrity of epididymal tight junctions provide a target that can be assessed to examine the integrity of the bloodepididymis barrier. Future studies on the role of other CLDNs may provide new insights toward understanding the necessity of expression of a large number of CLDNs in the epididymis and how these regulate sperm maturation. Furthermore, the use of human cell lines developed in this study provides an essential tool to examine the regulation of junctional proteins in the epididymis for the development of novel strategies that could eventually target the blood-epididymis barrier in infertile patients with altered barrier function.
